Uniwersytecki Szpital Kliniczny w Białymstoku

Bialystok 15-276

2 studies enrolling now · 10 studies all time

What they study most

Acute Myocardial Infarction, Cardiogenic Shock, Depression, Depression - Major Depressive Disorder, Depression Disorder, Depression Disorders, Depression in Adults, Fallopian Tube Neoplasms, Hypertension, Major Depressive Disorder (MDD), Neoplasm Metastasis, Ovarian Neoplasms

Studies at this site

• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder — Recruiting now
• A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 — Running, not enrolling
• A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2 — Running, not enrolling
• A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening) — Running, not enrolling
• Evaluation in STEMI Patients Using FDY-5301 — Completed
• A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C — Running, not enrolling
• The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock — Completed
• A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC — Status unconfirmed
• Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension — Completed